# ResearchChem

> ResearchChem (researchchem.org) is a US supplier of research-grade peptide
> compounds — 99.6% purity, third-party tested, cold-chain shipped. All products
> are sold strictly for laboratory research use only (RUO) and are not for human
> consumption. Not affiliated with researchchem.co, researchchemhq.co, or
> researchchemofficial.com.

Canonical store: https://researchchem.org
Support: support@researchchem.org · +1 (949) 739-0658

## Catalog detail

### Wolverine Stack — TB-500 + BPC-157
URL: https://researchchem.org/shop/wolverine
Sizes & prices: 20mg $100 (SKU WOLV-20)
Category: Stacks · Form: vial
Purity: 99.6% · Storage: -20°C · Reconstitution: BAC H₂O
Per-vial contents: TB-500 10mg, BPC-157 10mg

Q: What is Wolverine Stack?
A: Our most popular recovery stack — TB-500 (a thymosin beta-4 fragment) paired with BPC-157 (Body Protection Compound, a synthetic gastric peptide), 20mg combined. In research these two are studied together for tissue repair, angiogenesis (new blood-vessel formation), cell migration, and recovery signaling in tendon, ligament, and muscle models. Researchers often choose the stack over either peptide alone for the combined repair pathways.

Q: How much does Wolverine Stack cost at ResearchChem?
A: 20mg: $100.

Research use only — not for human or veterinary consumption.

### KLOW 80 — BPC-157 + TB-500 + GHK-Cu + KPV
URL: https://researchchem.org/shop/klow80
Sizes & prices: 80mg $120 (SKU KLOW-80)
Category: Stacks · Form: vial
Purity: 99.6% · Storage: -20°C · Reconstitution: BAC H₂O
Per-vial contents: BPC-157 10mg, TB-500 10mg, GHK-Cu 50mg, KPV 10mg

Q: What is KLOW 80?
A: A four-compound "repair matrix," 80mg total: BPC-157 and TB-500 for regenerative signaling, GHK-Cu (a copper-binding peptide) studied for collagen synthesis, skin remodeling and wound-healing research, and KPV (an alpha-MSH fragment) studied for anti-inflammatory and gut-barrier research. The most complete regenerative blend we carry — great value at 80mg for the price of the 20mg stack.

Q: How much does KLOW 80 cost at ResearchChem?
A: 80mg: $120.

Research use only — not for human or veterinary consumption.

### Retatrutide — Tri-Agonist Peptide
URL: https://researchchem.org/shop/reta-20
Sizes & prices: 10mg $60 (SKU RETA-10); 20mg $100 (SKU RETA-20); 30mg $130 (SKU RETA-30); 40mg $160 (SKU RETA-40)
Category: Peptides · Form: vial
Purity: 99.6% · Storage: -20°C · Reconstitution: BAC H₂O

Q: What is Retatrutide?
A: The smaller 10mg presentation of Retatrutide, the investigational GIP/GLP-1/glucagon triple receptor agonist. Same compound as our 20mg and 40mg — this is the lower-commitment size for researchers starting out. The 20mg at $100 and 40mg at $160 are better value per mg. Research use only.

Q: How much does Retatrutide cost at ResearchChem?
A: 10mg: $60; 20mg: $100; 30mg: $130; 40mg: $160.

Research use only — not for human or veterinary consumption.

### Tirzepatide — Dual-Agonist Peptide
URL: https://researchchem.org/shop/tirzepatide
Sizes & prices: 40mg $120 (SKU TIRZ-40)
Category: Peptides · Form: vial
Purity: 99.6% · Storage: -20°C · Reconstitution: BAC H₂O

Q: What is Tirzepatide?
A: A dual GIP and GLP-1 receptor agonist. In metabolic research it is studied for glucose regulation, insulin sensitivity, energy balance, and appetite-signaling pathways. The most-studied compound in its class, and the natural comparison to Retatrutide — Tirzepatide hits two receptors, Retatrutide three. A large 40mg vial at $150. Research use only.

Q: How much does Tirzepatide cost at ResearchChem?
A: 40mg: $120.

Research use only — not for human or veterinary consumption.

### CJC-1295 + Ipamorelin — GH Peptide Stack
URL: https://researchchem.org/shop/cjc-ipa
Sizes & prices: 5mg + 5mg $65 (SKU CJCIPA-55)
Category: Stacks · Form: vial
Purity: 99.6% · Storage: -20°C · Reconstitution: BAC H₂O
Per-vial contents: CJC-1295 5mg, Ipamorelin 5mg

Q: What is CJC-1295 + Ipamorelin?
A: A growth-hormone secretagogue pairing: CJC-1295 (a GHRH analog) with Ipamorelin (a selective ghrelin-receptor/GH secretagogue), 5mg each. Studied together in growth-hormone-axis research because they act on complementary pathways to produce a stronger, cleaner GH pulse in research models than either alone. Ipamorelin is favored in research for its selectivity.

Q: How much does CJC-1295 + Ipamorelin cost at ResearchChem?
A: 5mg + 5mg: $65.

Research use only — not for human or veterinary consumption.

### Ipamorelin — GH Secretagogue
URL: https://researchchem.org/shop/ipamorelin
Sizes & prices: 10mg $40 (SKU IPAM-10)
Category: Peptides · Form: vial
Purity: 99.6% · Storage: -20°C · Reconstitution: BAC H₂O

Q: What is Ipamorelin?
A: A selective growth-hormone secretagogue and ghrelin-receptor agonist. In research it is studied for pulsatile GH release with minimal effect on cortisol or prolactin, which is why it is favored for its selectivity. This is the standalone 10mg — the same peptide featured in our CJC-1295 + Ipamorelin stack, for researchers who want Ipamorelin on its own.

Q: How much does Ipamorelin cost at ResearchChem?
A: 10mg: $40.

Research use only — not for human or veterinary consumption.

### Tesamorelin — GHRH Analog
URL: https://researchchem.org/shop/tesamorelin
Sizes & prices: 10mg $60 (SKU TESA-10)
Category: Peptides · Form: vial
Purity: 99.6% · Storage: -20°C · Reconstitution: BAC H₂O

Q: What is Tesamorelin?
A: A stabilized growth-hormone-releasing hormone (GHRH) analog. In research it is studied for growth-hormone axis signaling, IGF-1 pathways, and visceral adipose tissue models. Often compared with the CJC-1295 + Ipamorelin stack — Tesamorelin is a GHRH analog on its own, where that stack pairs a GHRH analog with a ghrelin-receptor secretagogue. Research use only.

Q: How much does Tesamorelin cost at ResearchChem?
A: 10mg: $60.

Research use only — not for human or veterinary consumption.

### Melanotan 2 — Melanocortin Agonist
URL: https://researchchem.org/shop/melanotan2
Sizes & prices: 10mg $40 (SKU MT2-10)
Category: Peptides · Form: vial
Purity: 99.6% · Storage: -20°C · Reconstitution: BAC H₂O

Q: What is Melanotan 2?
A: A synthetic analog of alpha-MSH and a non-selective melanocortin receptor agonist. In research it is studied for melanogenesis and pigmentation signaling pathways. One of the most-requested research peptides we carry. Research use only.

Q: How much does Melanotan 2 cost at ResearchChem?
A: 10mg: $40.

Research use only — not for human or veterinary consumption.

### Semax — Nootropic Peptide
URL: https://researchchem.org/shop/semax
Sizes & prices: 10mg $45 (SKU SEMAX-10)
Category: Nootropics · Form: vial
Purity: 99.6% · Storage: -20°C · Reconstitution: BAC H₂O

Q: What is Semax?
A: A Russian-developed nootropic peptide derived from an ACTH fragment. In research it is studied for neuroprotection, BDNF (brain-derived neurotrophic factor) expression, focus, and cognition. Often researched alongside Selank for complementary neuro pathways.

Q: How much does Semax cost at ResearchChem?
A: 10mg: $45.

Research use only — not for human or veterinary consumption.

### Selank — Anxiolytic Peptide
URL: https://researchchem.org/shop/selank
Sizes & prices: 10mg $45 (SKU SLNK-10)
Category: Nootropics · Form: vial
Purity: 99.6% · Storage: -20°C · Reconstitution: BAC H₂O

Q: What is Selank?
A: An anxiolytic peptide based on the immunopeptide tuftsin. Studied in research for anxiety and stress models, GABAergic signaling, and immune modulation. Frequently paired with Semax in research settings — the calm-and-focus combination.

Q: How much does Selank cost at ResearchChem?
A: 10mg: $45.

Research use only — not for human or veterinary consumption.

### MOTS-c — Mitochondrial Peptide
URL: https://researchchem.org/shop/mots-c
Sizes & prices: 10mg $50 (SKU MOTS-10)
Category: Longevity · Form: vial
Purity: 99.6% · Storage: -20°C · Reconstitution: BAC H₂O

Q: What is MOTS-c?
A: A mitochondrial-derived peptide encoded in mitochondrial DNA rather than the cell nucleus. In research it is studied for metabolic regulation, AMPK signaling, insulin sensitivity, exercise capacity, and aging models. Often researched alongside NAD+ for the mitochondrial and cellular-energy pathways. Research use only.

Q: How much does MOTS-c cost at ResearchChem?
A: 10mg: $50.

Research use only — not for human or veterinary consumption.

### NAD+ — Coenzyme
URL: https://researchchem.org/shop/nad-1000
Sizes & prices: 1000mg $50 (SKU NAD-1000)
Category: Longevity · Form: vial
Purity: 99.6% · Storage: -20°C · Reconstitution: BAC H₂O

Q: What is NAD+?
A: Nicotinamide adenine dinucleotide, a coenzyme present in every cell. Studied in research for cellular energy metabolism, mitochondrial function, sirtuin activity, DNA-repair pathways, and aging models. A high 1000mg presentation. Research use only.

Q: How much does NAD+ cost at ResearchChem?
A: 1000mg: $50.

Research use only — not for human or veterinary consumption.

### DIY Spray Kit — Saline + Labeled Spray Bottle
URL: https://researchchem.org/shop/diy-spray-kit
Sizes & prices: 3 x 5ml $25 (SKU SPRAY-KIT)
Category: Supplies · Form: kit
Storage: Room Temp

Q: What is DIY Spray Kit?
A: Three sealed 5ml vials of sterile 0.9% saline (sodium chloride and water) plus one empty spray bottle, labeled with the compound you choose at checkout. The compound itself is not included — it is purchased separately at its normal price. Compatible compounds: Semax, Selank, NAD+, PT-141, DSIP and Glutathione. Research use only.

Q: How much does DIY Spray Kit cost at ResearchChem?
A: 3 x 5ml: $25.

Research use only — not for human or veterinary consumption.

### Glutathione — Antioxidant Tripeptide
URL: https://researchchem.org/shop/glutathione
Sizes & prices: 1500mg $35 (SKU GLUT-1500)
Category: Peptides · Form: vial
Purity: 99.6% · Storage: -20°C · Reconstitution: BAC H₂O

Q: What is Glutathione?
A: A tripeptide (glutamate, cysteine, glycine) studied in research as the cell's primary endogenous antioxidant, in oxidative-stress, redox-signaling and detoxification-pathway models. Research use only.

Q: How much does Glutathione cost at ResearchChem?
A: 1500mg: $35.

Research use only — not for human or veterinary consumption.

### PT-141 — Melanocortin Peptide
URL: https://researchchem.org/shop/pt-141
Sizes & prices: 10mg $45 (SKU PT141-10)
Category: Peptides · Form: vial
Purity: 99.6% · Storage: -20°C · Reconstitution: BAC H₂O

Q: What is PT-141?
A: Bremelanotide (PT-141), a cyclic melanocortin-receptor agonist derived from Melanotan II. Studied in research for central melanocortin-4 receptor signaling. Research use only.

Q: How much does PT-141 cost at ResearchChem?
A: 10mg: $45.

Research use only — not for human or veterinary consumption.

### DSIP — Delta Sleep-Inducing Peptide
URL: https://researchchem.org/shop/dsip
Sizes & prices: 10mg $55 (SKU DSIP-10)
Category: Peptides · Form: vial
Purity: 99.6% · Storage: -20°C · Reconstitution: BAC H₂O

Q: What is DSIP?
A: Delta sleep-inducing peptide, a nonapeptide first isolated in sleep research. Studied for sleep-architecture, stress-response and neuromodulation models. Research use only.

Q: How much does DSIP cost at ResearchChem?
A: 10mg: $55.

Research use only — not for human or veterinary consumption.

### HGH — Somatropin · 191 AA
URL: https://researchchem.org/shop/hgh
Sizes & prices: 24 IU $85 (SKU HGH-24)
Category: Peptides · Form: vial
Purity: 99.6% · Storage: 2-8°C · Reconstitution: BAC H₂O

Q: What is HGH?
A: Somatropin, the 191-amino-acid recombinant human growth hormone. In research it is studied for IGF-1 signaling, protein synthesis, lipolysis, and tissue growth and repair pathways. 24 IU per vial, lyophilized; store at 2-8°C. Research use only.

Q: How much does HGH cost at ResearchChem?
A: 24 IU: $85.

Research use only — not for human or veterinary consumption.

### GHK-Cu — Copper Tripeptide
URL: https://researchchem.org/shop/ghk-cu
Sizes & prices: free with any $50+ order
Category: Peptides · Form: vial
Purity: 99.6% · Storage: -20°C · Reconstitution: BAC H₂O

Q: What is GHK-Cu?
A: GHK-Cu, the copper-binding tripeptide (glycyl-L-histidyl-L-lysine copper complex). In research it is studied for collagen synthesis, skin remodeling, wound healing, and antioxidant gene-expression pathways. Not sold on its own: one 100mg vial is included FREE with any order of $50 or more. Research use only.

Q: How much does GHK-Cu cost at ResearchChem?
A: It is not sold separately; free with any $50+ order.

Research use only — not for human or veterinary consumption.

### Bacteriostatic Water — Reconstitution Solvent
URL: https://researchchem.org/shop/bac-water
Sizes & prices: 10ml $10 (SKU BACH2O-10); 3ml $6 (SKU BACH2O-3)
Category: Supplies · Form: solvent
Purity: 0.9% BnOH · Storage: Room Temp

Q: What is Bacteriostatic Water?
A: Sterile water with 0.9% benzyl alcohol, used to reconstitute lyophilized (freeze-dried) peptides for research handling. Not a peptide itself — it is the solvent. Most researchers add a vial or two to any peptide order.

Q: How much does Bacteriostatic Water cost at ResearchChem?
A: 10ml: $10; 3ml: $6.

Research use only — not for human or veterinary consumption.

Quantity discount: 5% per additional vial, capped at 20%.

## Shipping & delivery

- Ground shipping: $8.95 flat, US-wide, cold-chain packed; ships next business day, typically arrives within 3 business days.

## Quality pipeline

### 01 · GMP-Grade Synthesis
All compounds are synthesized using solid-phase peptide synthesis (SPPS) in ISO-certified cleanroom environments following Good Manufacturing Practice protocols.

### 02 · HPLC Purification
Crude peptides undergo reverse-phase HPLC purification to isolate the target compound at 99.6% purity. Multiple purification cycles ensure consistency across batches.

### 03 · Mass Spectrometry Verification
ESI-MS and MALDI-TOF confirm molecular identity and detect impurities at the parts-per-million level. Every batch is verified against the expected molecular weight.

### 04 · Lyophilization & Packaging
Purified peptides are lyophilized (freeze-dried) into stable powder form, sealed under nitrogen in Type I borosilicate glass vials with aluminum crimp seals.

### 05 · Independent Lab Testing
Third-party accredited laboratories run independent purity, identity, and sterility testing. Results are documented in a Certificate of Analysis (COA) for every lot.

### 06 · Cold-Chain Distribution
Temperature-sensitive compounds ship in insulated packaging with gel ice packs. Tracking ensures chain-of-custody from our facility to your lab.

## Shipping & Delivery

### 3-Day Ground
Cold-chain insulated shipping anywhere in the US, typically arriving within 3 business days. A flat handling rate applies.

### Cold Chain
Temperature-sensitive compounds ship in insulated packaging. Refrigerate or freeze on arrival per each product's storage guidance.

## Research-Use Disclaimer

### Not For Human Consumption
Every product sold by ResearchChem is a laboratory reagent intended for in-vitro research and laboratory experimentation ONLY. Products are not for human or animal consumption, ingestion, injection, or any form of in-vivo use.

### No Medical Claims
Nothing on this site is medical advice. Our products are not drugs or dietary supplements, are not approved by the FDA for human use, and are not intended to diagnose, treat, cure, or prevent any disease or condition. Any reference to a compound's studied properties describes published research, not a claim about our products.

### Buyer Responsibility
By purchasing, you confirm you are a qualified researcher or institution, that you will handle, store, and dispose of materials in accordance with all applicable laws and safety practices, and that you accept full responsibility for their use. Misuse is strictly prohibited.

### Third-Party Content
Community videos and external links are provided for reference only. They are created by third parties, are not endorsed or verified by ResearchChem, and are not medical or usage guidance.

## Frequently asked questions

Q: Are these products for human use?
A: No. All products are laboratory reagents for in-vitro research use only — not for human or veterinary consumption. See our Research-Use Disclaimer.

Q: How pure are your compounds?
A: Our peptides test at 99.6% purity and are third-party lab tested. A Certificate of Analysis (COA) is available for every batch — email support@researchchem.org with your lot number.

Q: How is my delivery fee calculated?
A: Courier delivery is a flat fee shown as a single total at checkout. 3-Day Ground is a flat rate.

Q: What is the RC Tracker?
A: A free tool for account holders to track research inventory, log withdrawals, and get a heads-up before a vial runs low. It manages quantities only — no dosing or usage guidance.

Q: How do I pay?
A: Card or crypto. Card payments are securely processed by TagadaPay — we never store your card number.

## Research library

### Semaglutide vs Tirzepatide: Receptor Pharmacology Compared

URL: https://researchchem.org/research/semaglutide-vs-tirzepatide-mechanism · Updated 2026-10-12

Short answer: Semaglutide and tirzepatide are both long-acting, fatty-acid-modified incretin peptides, but they act on different receptors. Semaglutide is a selective glucagon-like peptide-1 (GLP-1) receptor agonist derived from the native GLP-1 sequence. Tirzepatide is a single peptide that activates both the glucose-dependent insulinotropic polypeptide (GIP) receptor and the GLP-1 receptor. In head-to-head clinical research, tirzepatide produced larger reductions in HbA1c and body weight than semaglutide. Mechanistic studies linked this to greater improvements in insulin sensitivity, insulin secretion and glucagon suppression. How much the GIP-receptor component adds on its own is still being studied.

#### Which receptors do semaglutide and tirzepatide target?
GLP-1 and GIP are the two main incretin hormones: gut-derived peptides that increase glucose-dependent insulin secretion after a meal. Each acts through its own G-protein-coupled receptor, the GLP-1 receptor (GLP-1R) and the GIP receptor (GIPR). The main pharmacological difference between these two compounds is which of those receptors they engage.

Semaglutide is a GLP-1 analogue designed to act at GLP-1R alone. Tirzepatide, first described in the literature as LY3298176, was developed as a single peptide that activates both GIPR and GLP-1R. Reviews describe it as the first dual GIP/GLP-1 receptor co-agonist approved for type 2 diabetes. Studies that compare the two are therefore testing more than potency or formulation. They test whether adding GIP-receptor agonism to GLP-1-receptor agonism changes the metabolic outcome.

Feature | Semaglutide | Tirzepatide
Receptor target(s) | GLP-1 receptor | GIP receptor and GLP-1 receptor
Design basis | GLP-1 analogue with Aib8 and Arg34 substitutions and a modified Lys26 | Fatty-acid-modified peptide built for dual-receptor agonism
Protraction strategy | Fatty acid moiety and linker tuned for albumin binding | Fatty acid modification supporting once-weekly profile
Head-to-head clinical comparator | Reference arm in SURPASS-2 | Superior HbA1c and weight reductions vs semaglutide in SURPASS-2

#### How was semaglutide engineered for a long half-life?
Semaglutide was designed as a successor to liraglutide, a once-daily GLP-1 analogue that already bound albumin. The goal was a once-weekly analogue with higher albumin affinity and full metabolic stability. The developers reported that the fatty acid moiety and its linker were the key structural levers. Those groups had to raise albumin affinity enough to extend circulation without giving up too much GLP-1 receptor potency.

The selected molecule carries two amino acid substitutions, Aib8 and Arg34, plus a modification at lysine 26. Its GLP-1 receptor affinity was reported as about three-fold lower than liraglutide's, while its albumin affinity was higher. That trade-off was accepted in exchange for a longer duration of action. In mini-pigs, the plasma half-life after intravenous administration was 46.1 hours, and the mean residence time after subcutaneous administration was 63.6 hours. Those figures are preclinical, measured in mini-pigs, and should not be read as human pharmacokinetic values.

#### How was tirzepatide designed as a dual agonist?
Tirzepatide's discovery paper describes LY3298176 as a fatty-acid-modified peptide intended for once-weekly use. It activates both the GIP and GLP-1 receptors. In mice, the compound improved glucose tolerance and reduced body weight and food intake more than a GLP-1 receptor agonist alone. This was the first preclinical signal that dual-receptor agonism might do more than GLP-1R agonism by itself.

The same paper reported a Phase 1 program of 142 subjects, including healthy volunteers and people with type 2 diabetes, with dulaglutide as a positive control. Fasting serum glucose fell significantly versus placebo, body weight decreased, and the adverse events were mainly dose-dependent gastrointestinal events of mild to moderate severity. These were early clinical proof-of-concept findings, not efficacy comparisons with semaglutide.

#### What did the head-to-head SURPASS-2 trial find?
The most direct clinical comparison is SURPASS-2. This open-label, 40-week Phase 3 trial randomized 1,879 participants with type 2 diabetes to one of three tirzepatide dose levels or to semaglutide. Mean HbA1c changes from baseline were -2.01, -2.24 and -2.30 percentage points across the tirzepatide arms, compared with -1.86 percentage points for semaglutide. Tirzepatide was noninferior and superior to semaglutide at every dose level tested.

Body-weight reductions were also greater with tirzepatide, with treatment differences versus semaglutide of -1.9, -3.6 and -5.5 kg across the three tirzepatide arms. Gastrointestinal events were the most common adverse events with both compounds. A 2022 review of the SURPASS 1–5 program reached the same overall conclusion: tirzepatide outperformed semaglutide on glycaemic control and weight reduction, with a side-effect profile that resembled GLP-1 receptor agonists.

#### What do mechanistic studies show about islet function?
Outcome trials show that tirzepatide lowers glucose and body weight more than semaglutide, but not why. A dedicated mechanistic trial helps answer that. It was a 28-week, randomized, double-blind, parallel-arm study in 117 adults with type 2 diabetes comparing tirzepatide, semaglutide and placebo. Tirzepatide improved the clamp disposition index, a combined measure of insulin secretion and insulin sensitivity, more than both placebo and semaglutide. Compared with semaglutide, it also produced greater gains in total insulin secretion and insulin sensitivity. During meal testing, it lowered glucose excursions, insulin and glucagon more than either comparator.

A model-based reanalysis of the mixed-meal tolerance tests from that trial gave a more detailed picture. Compared with semaglutide, tirzepatide lowered fasting glucose and total glucose area under the curve significantly more. Incremental glucose area under the curve did not differ significantly, so most of the difference in total exposure came from lower fasting glucose. Tirzepatide also improved insulin sensitivity and reduced glucagon area under the curve more than semaglutide. The estimated hepatic insulin-to-glucagon ratio did not change substantially with either treatment. The authors attributed tirzepatide's greater glycaemic effect to combined improvements in insulin secretion, insulin sensitivity and glucagon suppression.

#### Is the GIP component responsible for the difference?
Not conclusively. Reviewers note that tirzepatide's mechanism of action is not fully settled. GIP's appetite-reducing effects have been shown in rodents but not yet in humans. It is also unclear whether GIP-receptor agonism itself improves insulin secretion in type 2 diabetes. The mouse data showing tirzepatide beating a GLP-1 agonist alone fits a GIP contribution, but it does not isolate one.

For researchers designing comparison studies, the practical point is that these two compounds differ in more than one way at once. They differ in receptor coverage, peptide backbone and fatty-acid protraction chemistry. Differences in outcome cannot automatically be credited to GIPR engagement unless the study design controls for exposure and GLP-1R activity.

#### How does the cardiovascular evidence compare?
The two compounds are at different stages of outcome research. A 2026 narrative review found that tirzepatide shows greater metabolic efficacy in head-to-head trials. Semaglutide, however, has the more established cardiovascular risk-reduction evidence base, from the SUSTAIN-6, PIONEER-6 and SELECT programs. For tirzepatide, SURPASS-CVOT showed cardiovascular non-inferiority to dulaglutide, and real-world cardiovascular findings were mixed. An earlier pooled analysis cited in a 2022 review found no major adverse cardiovascular event component with a hazard ratio above 1.0 for tirzepatide versus comparators.

#### FAQ
Q: What is the main mechanistic difference between semaglutide and tirzepatide?
A: Semaglutide activates only the GLP-1 receptor. Tirzepatide is a single peptide that activates both the GIP receptor and the GLP-1 receptor.

Q: Why do both compounds last a long time in circulation?
A: Both carry fatty-acid modifications. In semaglutide's case, the fatty acid and linker were chosen to increase albumin binding, which extends its circulating half-life.

Q: Did tirzepatide outperform semaglutide in a direct comparison?
A: Yes. In the 40-week SURPASS-2 trial, tirzepatide reduced HbA1c and body weight more than semaglutide at all three dose levels tested.

Q: Does the GIP component explain tirzepatide's larger effect?
A: It has not been proven. Reviewers note that GIP's appetite effects have been shown in rodents but not in humans, and its role in insulin secretion in type 2 diabetes is still unclear.

Q: Which compound has more cardiovascular outcome data?
A: Semaglutide has the more established cardiovascular risk-reduction evidence. Tirzepatide has shown non-inferiority to dulaglutide in SURPASS-CVOT.

#### Sources
1. Lau J, Bloch P, Schäffer L, et al. Discovery of the Once-Weekly Glucagon-Like Peptide-1 (GLP-1) Analogue Semaglutide.. J Med Chem. 58(18):7370-7380 (2015). PMID 26308095
2. Coskun T, Sloop KW, Loghin C, et al. LY3298176, a novel dual GIP and GLP-1 receptor agonist for the treatment of type 2 diabetes mellitus: From discovery to clinical proof of concept.. Mol Metab. 18:3-14 (2018). PMID 30473097
3. Frías JP, Davies MJ, Rosenstock J, et al. Tirzepatide versus Semaglutide Once Weekly in Patients with Type 2 Diabetes.. N Engl J Med. 385(6):503-515 (2021). PMID 34170647
4. Heise T, Mari A, DeVries JH, et al. Effects of subcutaneous tirzepatide versus placebo or semaglutide on pancreatic islet function and insulin sensitivity in adults with type 2 diabetes: a multicentre, randomised, double-blind, parallel-arm, phase 1 clinical trial.. Lancet Diabetes Endocrinol. 10(6):418-429 (2022). PMID 35468322
5. Nauck MA, D'Alessio DA. Tirzepatide, a dual GIP/GLP-1 receptor co-agonist for the treatment of type 2 diabetes with unmatched effectiveness regrading glycaemic control and body weight reduction.. Cardiovasc Diabetol. 21(1):169 (2022). PMID 36050763
6. Mather KJ, Mari A, Heise T, et al. Effects of Tirzepatide vs Semaglutide on β-Cell Function, Insulin Sensitivity, and Glucose Control During a Meal Test.. J Clin Endocrinol Metab. 109(12):3046-3054 (2024). PMID 38795393
7. Harbi MH, Ashour AM, Alorfi NM, et al. Tirzepatide vs. semaglutide for obesity, glycemic control, and cardiovascular outcomes: a narrative review of clinical trials.. Front Med (Lausanne). 13:1764664 (2026). PMID 42100257

### GHK-Cu Peptide: Published Research on the Copper Tripeptide

URL: https://researchchem.org/research/ghk-cu-peptide-research · Updated 2026-10-11

Short answer: GHK-Cu is the copper(II) complex of glycyl-L-histidyl-L-lysine (GHK), a tripeptide first described as an activity in human albumin and later isolated from human plasma. Published research centres on its role in tissue remodeling: cell-culture work showed it stimulates collagen synthesis by fibroblasts, and reviews describe effects on elastin, glycosaminoglycans, metalloproteinases, angiogenesis and inflammatory signalling. Gene-expression analyses report that GHK can shift the expression of thousands of human genes. Most of the evidence is preclinical, however. A 2026 systematic evidence-mapping review concluded that controlled clinical evidence remains sparse and that GHK-Cu should be treated as promising but unproven.

#### What is GHK-Cu?
GHK is the tripeptide glycyl-L-histidyl-L-lysine. According to a 2012 review, it was discovered in 1973 as an activity in human albumin that caused old human liver tissue to synthesize proteins like younger tissue; it has a high affinity for copper ions and readily forms the copper complex GHK-Cu. An earlier review notes that GHK's affinity for Cu(2+) is similar to the copper transport site on albumin.

GHK is reported to be present in human plasma, saliva and urine, with levels that decline with age, and it is proposed to function as a complex with copper 2+. Research catalogues therefore distinguish the apo-peptide (GHK) from the copper complex (GHK-Cu), a distinction that a 2026 formulation review argues is often blurred in the literature.

#### What did the early collagen studies show?
The foundational in-vitro paper is Maquart and colleagues (1988), which reported that GHK-Cu stimulated collagen synthesis in fibroblast cultures. Stimulation began between 10^-12 and 10^-11 M, was maximal at 10^-9 M, and was independent of any change in cell number.

The same authors pointed out that a GHK triplet occurs in the alpha 2(I) chain of type I collagen, suggesting the tripeptide could be liberated by proteases at a wound site and act locally. That hypothesis, GHK as a matrix-derived repair signal, frames much of the research that followed.

#### How is GHK-Cu linked to tissue remodeling?
A 2008 review grouped the reported activities of GHK and GHK-Cu into four clusters: chemoattraction of repair cells such as macrophages, mast cells and capillary cells; anti-inflammatory actions, including suppression of free radicals, thromboxane formation, transforming growth factor beta-1 and tumor necrosis factor alpha alongside increased superoxide dismutase; increased synthesis of collagen, elastin, metalloproteinases, anti-proteases, vascular endothelial growth factor, fibroblast growth factor 2 and nerve growth factor; and increased proliferation of fibroblasts and keratinocytes, nerve outgrowth and angiogenesis.

A 2015 review added that GHK stimulates both synthesis and breakdown of collagen and glycosaminoglycans and modulates the activity of both metalloproteinases and their inhibitors, a balance consistent with remodeling rather than simple matrix build-up. It also lists stimulation of dermatan sulfate, chondroitin sulfate and the small proteoglycan decorin, and reports that the molecule restores replicative vitality to fibroblasts after radiation therapy.

Animal-model findings are summarised in the same reviews. The 2015 review reports that the molecule accelerates wound healing of the skin, hair follicles, gastrointestinal tract, bony tissue and the foot pads of dogs, and that it induces systemic wound healing in rats, mice and pigs. The 2008 review adds reports that GHK-Cu protects hepatic tissue from tetrachloromethane poisoning, blocks stomach ulcer development, and heals intestinal ulcers and bone tissue. Because these are review summaries, readers designing studies should return to the primary papers for models and methods.

Category | Reported activity | Source
Matrix synthesis | Collagen, elastin, glycosaminoglycans, decorin | Pickart 2008; Pickart 2015
Matrix turnover | Modulates metalloproteinases and their inhibitors | Pickart 2015
Cell recruitment | Chemoattraction of macrophages, mast cells, capillary cells | Pickart 2008
Redox / inflammation | Suppresses free radicals, TGF-beta-1, TNF-alpha; increases superoxide dismutase | Pickart 2008
Growth factors | VEGF, FGF-2, nerve growth factor | Pickart 2008
Gene expression | Up- and downregulates at least 4,000 human genes | Pickart 2015

#### What do the gene-expression data suggest?
Later work from the same group moved from individual endpoints to genome-wide expression data. The 2015 review states that GHK is capable of up- and downregulating at least 4,000 human genes. The 2018 review argues that recent genetic data may explain how one molecule shows such diverse actions, revealing multiple biochemical pathways regulated by GHK.

The 2018 review lists activities including stimulation of blood vessel and nerve outgrowth, support of dermal fibroblast function, restoration of COPD fibroblasts, suppression of NF-kappaB, DNA repair and activation of cell cleansing via the proteasome system. It reports tissue-repair findings for skin, lung connective tissue, bone, liver and stomach lining. The 2012 review extended this to neurobiology, citing the ability of GHK to regulate genes critical for neuronal development and maintenance and proposing it as a candidate for study in age-associated cognitive decline. These are hypothesis-generating reviews from a single research group, and the breadth of the claims should be read in that light.

#### What about antioxidant and anti-inflammatory research?
Antioxidant and anti-inflammatory effects recur across the literature. The 2012 review describes GHK as having antioxidant, anti-inflammatory and wound-healing properties, and frames oxidative stress and disrupted copper homeostasis as relevant research targets. The 2008 review also lists blocking ultraviolet damage to skin keratinocytes and improving fibroblast recovery after X-ray treatments among the anti-inflammatory and protective actions attributed to GHK and GHK-Cu.

A 2025 materials study offers a recent example. Researchers loaded GHK-Cu onto hydroxyapatite microspheres by electrostatic adsorption and formulated them into a gel. The material showed sustained release over 7 days, and in an LPS-induced inflammation model in vivo and in vitro it reduced inflammatory factors and reactive oxygen species while increasing superoxide dismutase activity; histology showed significant collagen deposition.

#### Why is formulation such a large part of GHK-Cu research?
GHK is small and hydrophilic, which shapes how it behaves in formulations. A 2025 review on topical GHK notes formulation challenges arising from its high aqueous solubility, low partition coefficient and unstable nature. It reports that metal complexation and chemical modification with a hydrophobic moiety (as in palmitoylated Pal-GHK) increase permeability, and that cell-penetrating peptides and microneedle pretreatment are being studied as permeation-enhancement approaches.

The 2026 evidence-mapping review goes further, arguing that GHK-Cu is often treated as a single active ingredient despite formulation-dependent variation in coordination state, speciation, stability, pharmacokinetics and toxicity. Across delivery studies, it found that molar copper occupancy, labile copper, and release of intact GHK-Cu versus apo-GHK or free copper are usually not resolved. For laboratories sourcing material, this points to analytical characterisation of identity, purity and copper content as a prerequisite for interpretable results.

#### How strong is the clinical evidence?
Older reviews describe controlled studies on aged skin reporting tighter skin, improved elasticity and firmness, and fewer fine lines. More recent independent reviews are more cautious. The 2025 topical review found a surprising absence of clinical studies using GHK-Cu and Pal-GHK, despite their wide use in anti-wrinkle products.

The 2026 systematic evidence-mapping review concluded that preclinical data consistently support effects on matrix remodeling, epithelial repair, inflammatory and redox regulation, and angiogenesis, but that clinical evidence remains sparse. It notes that a 13-participant post-CO2-laser study was negative on objective endpoints, that a 2026 18-participant split-face study did not define GHK-Cu speciation or local exposure, and that the phase 2 acute-wound study NCT07437586 was still recruiting with no efficacy results. Its conclusion: GHK-Cu should be regarded as a promising but unproven therapeutic cargo rather than a clinically validated regenerative drug.

#### FAQ
Q: What is GHK-Cu?
A: GHK-Cu is the copper(II) complex of the tripeptide glycyl-L-histidyl-L-lysine (GHK). GHK was discovered in 1973 as an activity in human albumin and has a high affinity for copper ions.

Q: What was the first key finding on GHK-Cu and collagen?
A: A 1988 fibroblast-culture study reported that GHK-Cu stimulated collagen synthesis, beginning between 10^-12 and 10^-11 M and maximal at 10^-9 M, independent of changes in cell number.

Q: Does GHK affect gene expression?
A: Review articles report that GHK can up- and downregulate at least 4,000 human genes. These analyses come largely from one research group and are best treated as hypothesis-generating.

Q: Is GHK the same as GHK-Cu?
A: No. GHK is the apo-peptide and GHK-Cu is its copper complex. A 2026 review stresses that copper occupancy and speciation vary by formulation and are often not reported.

Q: Is GHK-Cu clinically proven?
A: No. A 2026 systematic evidence-mapping review found clinical evidence sparse and described GHK-Cu as promising but unproven. It is supplied for laboratory research use only.

#### Sources
1. Maquart FX, Pickart L, Laurent M, et al. Stimulation of collagen synthesis in fibroblast cultures by the tripeptide-copper complex glycyl-L-histidyl-L-lysine-Cu2+.. FEBS Lett. 238(2):343-6 (1988). PMID 3169264
2. Pickart L. The human tri-peptide GHK and tissue remodeling.. J Biomater Sci Polym Ed. 19(8):969-88 (2008). PMID 18644225
3. Pickart L, Vasquez-Soltero JM, Margolina A. The human tripeptide GHK-Cu in prevention of oxidative stress and degenerative conditions of aging: implications for cognitive health.. Oxid Med Cell Longev. 2012:324832 (2012). PMID 22666519
4. Pickart L, Vasquez-Soltero JM, Margolina A. GHK Peptide as a Natural Modulator of Multiple Cellular Pathways in Skin Regeneration.. Biomed Res Int. 2015:648108 (2015). PMID 26236730
5. Pickart L, Margolina A. Regenerative and Protective Actions of the GHK-Cu Peptide in the Light of the New Gene Data.. Int J Mol Sci. 19(7):1987 (2018). PMID 29986520
6. Mortazavi SM, Mohammadi Vadoud SA, Moghimi HR. Topically applied GHK as an anti-wrinkle peptide: Advantages, problems and prospective.. Bioimpacts. 15:30071 (2025). PMID 39963574
7. Hu D, Zhang X, Gong S, et al. An injectable hydroxyapatite microsphere filler loaded with GHK-Cu tripeptide for anti-Inflammatory and antioxidant.. Colloids Surf B Biointerfaces. 256(Pt 1):114982 (2025). PMID 40716276
8. Mateescu DM, Gavrilescu DM, Mincioaga RI, et al. GHK-Cu as a Bioactive Metallopeptide and Drug-Delivery Cargo: Coordination Chemistry, Formulation Science, Therapeutic Evidence, and a Translational Roadmap.. Pharmaceutics. 18(9):1077 (2026). PMID 42797253

### How to Read a Peptide Certificate of Analysis (COA)

URL: https://researchchem.org/research/peptide-certificate-of-analysis · Updated 2026-10-08

Short answer: A peptide certificate of analysis (COA) is the lab report for one specific production lot. A useful COA ties a lot number to an identity result (mass spectrometry), a purity result (HPLC area percent with the chromatogram), the test methods and acceptance limits, and the testing lab and date. Without a matching lot number, a COA describes some other vial.

#### What is a certificate of analysis for a research peptide?
A certificate of analysis is a document that reports the measured results for a single batch (lot) of material against a predefined specification. Regulators describe a specification as a list of tests, references to analytical procedures, and acceptance criteria — numerical limits, ranges or other criteria — that a material should conform to in order to be considered acceptable for its intended use. A COA is the evidence that one lot actually met that list.

For research peptides, the COA matters because a lyophilized (freeze-dried) peptide is a white powder: two vials of entirely different compounds can look identical. Only analytical data can tell you what is in the vial and how much of it is the intended sequence. Impurities in synthetic peptides are not only a quality issue; published reviews note they can influence early functionality studies enough to cause erroneous conclusions.

At ResearchChem, every batch ships with a lot number. Email the lot number to support@researchchem.org and we send the Certificate of Analysis for that exact batch, usually within 48 hours. See our quality pipeline.

#### What should a peptide COA include?
Formats differ between labs, but a COA that is useful for research documentation normally carries the following fields. If several are missing, treat the document as marketing rather than analysis.

Field | What it tells you | What to check
Product name and sequence | Which molecule was tested | Name matches the label; sequence or molecular formula given
Lot / batch number | Which production run the results belong to | Matches the lot printed on your vial
Identity (MS) | Measured molecular mass vs theoretical mass | Observed mass close to the theoretical value for the sequence
Purity (HPLC) | Share of UV-absorbing material that is the main peak | Percentage plus the chromatogram, column and wavelength
Peptide content (optional) | How much of the powder weight is peptide | Method stated, e.g. amino acid analysis
Endotoxin (optional) | Bacterial endotoxin level | Method named, e.g. LAL / USP <85>
Methods and limits | How each result was produced and what counts as a pass | An acceptance criterion next to every result
Lab, date, sign-off | Who tested it and when | Lab name, analysis date, analyst or QA signature

#### How does mass spectrometry confirm peptide identity?
Identity is the first question a COA must answer: is this the right molecule? Peptide identity is usually confirmed by mass spectrometry (MS), which measures the mass of intact molecular ions. Two "soft" ionization methods made this routine for peptides and proteins: electrospray ionization (ESI), which produces intact, multiply charged ions from molecules in solution, and matrix-assisted laser desorption ionization (MALDI), which was shown to ionize proteins above 10,000 daltons.

On the COA, look for the theoretical (calculated) mass from the sequence and the observed mass from the spectrum. ESI spectra typically show a series of peaks at different charge states for the same molecule, so a COA may list the deconvoluted mass rather than a single raw peak. What you are checking is simple: the observed mass corresponds to the sequence on the label.

Mass spectrometry answers "is the intended molecule present?" It does not, on its own, answer "how pure is it?" — that is the job of HPLC.

#### What does the HPLC purity number on a COA mean?
High-performance liquid chromatography (HPLC) separates the components of a sample so they can be measured individually. Reversed-phase HPLC is the standard mode for analyzing and purifying synthetic peptides. The sample passes through a column, components elute at different times, and a UV detector draws a chromatogram: one tall main peak for the target peptide and smaller peaks for anything else.

The purity figure is normally the area of the main peak divided by the total area of all integrated peaks, expressed as a percentage. A COA stating 99.6% HPLC purity means 99.6% of the UV-detected peak area belongs to the main peak under that method. This is why the method details matter: column, gradient and detection wavelength all affect what the chromatogram can resolve. Analytical guidelines frame this as "fitness for purpose" — a validated procedure has to demonstrate specificity, accuracy and precision over its reportable range.

The minor peaks are the impurities. In peptides made by solid-phase synthesis these commonly include deletion and insertion sequences, diastereomers from racemization, incompletely deprotected side chains, oxidized residues and dimers, plus degradation products that can form during storage. For a deeper walkthrough, see HPLC peptide purity explained.

#### Is HPLC purity the same as peptide content?
No — and this is the most commonly misread line on a peptide COA. HPLC purity describes the composition of the material that the detector sees. Peptide content (sometimes called net peptide content) describes how much of the powder's weight is actually peptide, as opposed to counter-ions and residual water that do not show up as peaks.

Counter-ions matter because peptides purified by reversed-phase HPLC are often isolated as trifluoroacetate (TFA) salts, since trifluoroacetic acid is used in the separation. Those counter-ions add weight without adding peptide. They can also matter experimentally: one study found TFA at nanomolar concentrations reduced proliferation of osteoblast and chondrocyte cultures, and that TFA salts of several peptides could mask or mimic biological effects compared with hydrochloride salts. Researchers running sensitive cell assays often take the salt form into account for exactly this reason.

Peptide content is measured by different methods than purity. A common reference approach is amino acid analysis: the peptide is hydrolyzed in acid, the released amino acids are quantified, and the peptide amount is calculated from its known sequence. If a COA reports only HPLC purity, it is telling you about purity, not about how many milligrams of peptide are in the vial.

#### What other tests can appear on a research peptide COA?
- Bacterial endotoxin. Usually measured with the limulus amebocyte lysate (LAL) assay, the compendial bacterial endotoxins test described in USP <85>. Results depend on careful, consistent sample handling — a published industry study traced inconsistent endotoxin recovery to sample-preparation differences rather than the product itself.
- Appearance. A visual description such as "white lyophilized powder".
- Water content or residual solvents. Reported by some labs; relevant to the purity-versus-content distinction above.
- Counter-ion. Some COAs state the salt form (for example acetate or TFA), which helps interpret peptide content.

Our own published quality specifications list HPLC purity, ESI-MS / MALDI-TOF identity confirmation and LAL endotoxin testing; see Research & Quality for the full pipeline.

#### What are the red flags on a peptide COA?
- No lot number, or a lot number that does not match your vial. The document cannot be connected to what you received.
- A purity percentage with no chromatogram, no method and no wavelength. There is nothing to verify.
- No identity test. A high HPLC purity for an unidentified main peak only proves the sample is uniform, not that it is the right compound.
- The same COA reused for every batch, or a date years older than the product.
- No laboratory name, date or signature.
- An observed mass that does not correspond to the stated sequence.
- Results without acceptance criteria. Without a stated limit, "pass" means nothing.

#### How do you get the COA for a ResearchChem batch?
Find the lot number on your vial or packing slip and email it to support@researchchem.org. We reply with the Certificate of Analysis for that exact lot — our stated turnaround is under 48 hours. Every peptide in our catalog, from Retatrutide and Tirzepatide to the CJC-1295 + Ipamorelin stack, is listed at 99.6% HPLC purity with third-party testing.

All ResearchChem products are laboratory reagents for in-vitro research use only. They are not for human or veterinary use, and nothing in this article is medical advice.

#### FAQ
Q: What does COA stand for in peptides?
A: COA stands for certificate of analysis: the lab report showing the measured results — identity, purity and any other tests — for one specific production lot of a peptide.

Q: Is 99% HPLC purity the same as 99% peptide?
A: No. HPLC purity is the share of detected peak area that belongs to the main peak. Peptide content is the share of the powder's weight that is peptide, which also accounts for counter-ions such as trifluoroacetate and residual water.

Q: Which test confirms a peptide is the right compound?
A: Mass spectrometry. ESI-MS or MALDI-TOF measures the molecular mass, which should match the theoretical mass calculated from the peptide sequence.

Q: Why does the lot number matter on a COA?
A: Results apply only to the batch that was tested. A COA whose lot number does not match your vial documents a different batch.

Q: How do I get a COA from ResearchChem?
A: Email the lot number on your vial to support@researchchem.org. We send the Certificate of Analysis for that exact batch, typically within 48 hours.

#### Sources
1. International Council for Harmonisation. Q6B: Specifications — Test Procedures and Acceptance Criteria for Biotechnological/Biological Products (definition of a specification; note the guideline itself excludes synthetic peptides from its scope). ICH Harmonised Tripartite Guideline (1999). https://database.ich.org/sites/default/files/Q6B%20Guideline.pdf
2. D'Hondt M, Bracke N, Taevernier L, et al. Related impurities in peptide medicines. J Pharm Biomed Anal. 101:2–30 (2014). PMID 25044089
3. Fenn JB, Mann M, Meng CK, Wong SF, Whitehouse CM. Electrospray ionization for mass spectrometry of large biomolecules. Science. 246(4926):64–71 (1989). PMID 2675315
4. Karas M, Hillenkamp F. Laser desorption ionization of proteins with molecular masses exceeding 10,000 daltons. Anal Chem. 60(20):2299–2301 (1988). PMID 3239801
5. Mant CT, Chen Y, Yan Z, et al. HPLC analysis and purification of peptides. Methods Mol Biol. 386:3–55 (2007). PMID 18604941
6. International Council for Harmonisation. Q2(R2): Validation of Analytical Procedures. ICH Harmonised Guideline (2023). https://database.ich.org/sites/default/files/ICH_Q2%28R2%29_Guideline_2023_1130.pdf
7. Cornish J, Callon KE, Lin CQ, et al. Trifluoroacetate, a contaminant in purified proteins, inhibits proliferation of osteoblasts and chondrocytes. Am J Physiol. 277(5):E779–E783 (1999). PMID 10567002
8. Qasrawi DO, Petrotchenko EV, Borchers CH. Amino acid analysis for peptide quantitation using reversed-phase liquid chromatography combined with multiple reaction monitoring mass spectrometry. Anal Bioanal Chem. 415(22):5261–5267 (2023). PMID 37468754
9. Bolden JS, Warburton RE, Phelan R, et al. Endotoxin recovery using limulus amebocyte lysate (LAL) assay. Biologicals. 44(5):434–440 (2016). PMID 27470947

### HPLC Peptide Purity Explained: What a 99.6% Result Means

URL: https://researchchem.org/research/hplc-peptide-purity · Updated 2026-10-08

Short answer: HPLC peptide purity is the percentage of a sample's UV-detected peak area that belongs to the target peptide's main peak. Reversed-phase HPLC separates the peptide from synthesis by-products and degradants, and detection near 210–220 nm sees the peptide bonds. A 99.6% result means minor peaks account for 0.4% of that area.

#### What is HPLC and why is it used for peptides?
High-performance liquid chromatography (HPLC) pumps a dissolved sample through a packed column. Components interact with the column's stationary phase to different degrees, so they leave (elute) at different times and can be detected and measured one by one. For peptides, the dominant mode is reversed-phase HPLC (RP-HPLC), which separates molecules largely by hydrophobicity. A widely cited methods review describes RP-HPLC as the most widely used HPLC mode for peptide separations and generally superior to other modes in speed and efficiency.

The same technique does two jobs in peptide production. Preparatively, it purifies crude synthetic peptide by collecting the main peak. Analytically, a separate run on the finished material produces the chromatogram that the purity figure on a certificate of analysis is calculated from.

#### How is HPLC purity calculated?
The detector output is a chromatogram: signal on the vertical axis, retention time on the horizontal axis. Each separated component appears as a peak, and the area under a peak is proportional to how much of that component the detector sees. Purity by "area percent" is then:

Purity (%) = area of the main peak ÷ total area of all integrated peaks × 100

Detection is usually by UV absorbance. Peptide bonds absorb strongly in the far ultraviolet, so peptides are generally detected at 210–220 nm; aromatic residues (tyrosine, phenylalanine, tryptophan) also absorb at 250–290 nm, but not every peptide contains them. That is why a purity value should always be reported with its detection wavelength — the backbone-absorbing range is what makes the measurement applicable to any peptide sequence.

#### What does 99.6% HPLC purity actually mean?
A 99.6% HPLC purity result says that, under the stated method, 99.6% of the integrated UV peak area is the main peak and 0.4% is everything else the method resolved. It is a relative measurement of the material the detector can see. Three practical consequences follow:

- It is method-dependent. Column chemistry, gradient steepness, mobile-phase additives and wavelength all change how well closely related impurities are separated from the main peak.
- It does not identify the main peak. A uniform sample of the wrong peptide could still show one large peak, which is why identity is confirmed separately by mass spectrometry.
- It is not a weight measurement. Water and counter-ions do not appear as peptide peaks, so HPLC purity says nothing about how many milligrams of peptide the powder contains (see below).

ResearchChem lists every peptide at 99.6% purity by HPLC, with identity confirmed by ESI-MS / MALDI-TOF and third-party testing documented in a certificate of analysis for every lot. Our full quality pipeline is on the Research & Quality page.

#### What are the small peaks on a peptide chromatogram?
Most research peptides are made by solid-phase peptide synthesis (SPPS). A review of related impurities in peptide medicines groups the minor species seen in such products into a few families:

Impurity type | Origin
Deletion sequences | An amino acid failed to couple, typically linked to inefficient Fmoc deprotection
Insertion sequences | An extra residue added, linked to excess amino-acid reagent
Diastereomers | Racemization of residues during deprotection
Protection adducts | Side-chain protecting groups not fully removed
Oxidation products | Oxidized amino-acid side chains
Dimers / oligomers | Two or more peptide chains linked together
Degradation products | Storage-related chemistry such as β-elimination, diketopiperazine, pyroglutamate or succinimide formation
Counter-ions | For example trifluoroacetate left from synthesis or purification

Because many of these species differ from the target by a single residue or a small modification, they can elute very close to the main peak. The same review notes that such impurities can greatly influence early functionality studies, possibly resulting in erroneous conclusions  — which is the practical reason purity is worth documenting for research material.

#### Is HPLC purity the same as peptide content?
No. Peptide content (net peptide content) is the fraction of the powder's weight that is peptide. Lyophilized peptides also carry counter-ions and residual water. Reversed-phase separations of peptides are typically run in aqueous trifluoroacetic acid (TFA) and acetonitrile, and HPLC-purified peptides are often isolated as TFA salts as a result. Those counter-ions add mass but no peptide peak.

Peptide content is measured with a different technique. In amino acid analysis, the peptide is hydrolyzed in acid, the individual amino acids are quantified, and the peptide amount is calculated from its known sequence. A sample can therefore be 99% pure by HPLC and still be well below 100% peptide by weight. When a protocol depends on exact peptide mass, researchers look for a peptide-content result rather than inferring it from purity.

The counter-ion can also matter biologically in vitro. In one study, trifluoroacetate at nanomolar concentrations reduced proliferation of osteoblast and chondrocyte cultures, and TFA salts of several peptides gave different results from the corresponding hydrochloride salts.

#### How do you know an HPLC purity method is reliable?
Regulatory analytical guidance frames this as validation: the objective is to demonstrate that an analytical procedure is fit for its intended purpose, typically by examining specificity/selectivity, accuracy and precision over the reportable range. For a purity method, specificity is the key property — the method must actually separate the analyte from likely impurities and degradation products.

One recognized way to show specificity is an orthogonal comparison: checking that the result agrees with a second, well-characterized procedure that ideally uses a different measurement principle. In peptide QC, pairing HPLC with mass spectrometry follows the same logic: HPLC quantifies how much of the sample is the main component, while MS — made routine for intact biomolecules by electrospray ionization  — confirms that the main component has the right mass.

#### What should you check on an HPLC chromatogram?
- The lot number on the report matches your vial.
- Column, mobile phase, gradient and detection wavelength are stated.
- One dominant main peak, with the integrated minor peaks listed or visible.
- The reported purity matches the peak table (main-peak area ÷ total area).
- A separate identity result (MS) for the same lot — see how to read a peptide COA.
- A date and the testing laboratory.

To request the chromatogram and COA for a ResearchChem batch, email the lot number to support@researchchem.org. All products are laboratory reagents for in-vitro research use only and are not for human or veterinary use.

#### FAQ
Q: What is a good HPLC purity for research peptides?
A: There is no universal threshold; it depends on the experiment. What matters is that the purity value comes with its method, wavelength, chromatogram and lot number. ResearchChem peptides are listed at 99.6% by HPLC.

Q: What wavelength is used for HPLC peptide purity?
A: Typically 210–220 nm, where peptide bonds absorb strongly. Aromatic residues also absorb at 250–290 nm, but not all peptides contain them.

Q: Does HPLC purity tell you how much peptide is in a vial?
A: No. HPLC purity is a relative peak-area measurement. The weight fraction that is peptide — peptide content — is measured separately, for example by amino acid analysis, because counter-ions and water add weight without appearing as peptide peaks.

Q: Can HPLC alone prove a peptide is what the label says?
A: No. HPLC shows how uniform a sample is; mass spectrometry confirms the main component has the expected molecular mass. A reliable COA reports both.

Q: What causes impurity peaks in synthetic peptides?
A: Mostly synthesis by-products — deletion or insertion sequences, diastereomers, incompletely removed protecting groups, oxidation, dimers — plus degradation products that can form during storage.

#### Sources
1. Mant CT, Chen Y, Yan Z, et al. HPLC analysis and purification of peptides. Methods Mol Biol. 386:3–55 (2007). PMID 18604941
2. D'Hondt M, Bracke N, Taevernier L, et al. Related impurities in peptide medicines. J Pharm Biomed Anal. 101:2–30 (2014). PMID 25044089
3. Cornish J, Callon KE, Lin CQ, et al. Trifluoroacetate, a contaminant in purified proteins, inhibits proliferation of osteoblasts and chondrocytes. Am J Physiol. 277(5):E779–E783 (1999). PMID 10567002
4. Qasrawi DO, Petrotchenko EV, Borchers CH. Amino acid analysis for peptide quantitation using reversed-phase liquid chromatography combined with multiple reaction monitoring mass spectrometry. Anal Bioanal Chem. 415(22):5261–5267 (2023). PMID 37468754
5. International Council for Harmonisation. Q2(R2): Validation of Analytical Procedures. ICH Harmonised Guideline (2023). https://database.ich.org/sites/default/files/ICH_Q2%28R2%29_Guideline_2023_1130.pdf
6. Fenn JB, Mann M, Meng CK, Wong SF, Whitehouse CM. Electrospray ionization for mass spectrometry of large biomolecules. Science. 246(4926):64–71 (1989). PMID 2675315

### CJC-1295 vs Ipamorelin: Mechanism, Half-Life and Published Research

URL: https://researchchem.org/research/cjc-1295-vs-ipamorelin · Updated 2026-10-08

Short answer: CJC-1295 and Ipamorelin both raise growth hormone (GH) release in research models, through different receptors. CJC-1295 is a modified GHRH analog that binds serum albumin, with a reported half-life of about 6–8 days. Ipamorelin is a five-residue ghrelin-receptor agonist with a roughly 2-hour half-life, noted for releasing GH without raising ACTH or cortisol.

#### How is growth hormone release regulated?
Pituitary GH secretion is controlled by more than one signal. Growth-hormone-releasing hormone (GHRH) from the hypothalamus acts on its own receptor. A second receptor, the growth hormone secretagogue receptor (GHS-R), was cloned in 1996 from pituitary and hypothalamus and shown to be the target of synthetic GH secretagogues. Its natural ligand, ghrelin, was identified in 1999 as a 28-amino-acid acylated peptide from the stomach, establishing that GH release can be regulated through a pathway distinct from GHRH.

CJC-1295 and Ipamorelin sit on opposite sides of this picture: CJC-1295 is a GHRH-receptor agonist, while Ipamorelin is a GHS-R (ghrelin-receptor) agonist. That difference explains most of the comparison below.

#### What is CJC-1295?
CJC-1295 is a synthetic analog of GHRH(1-29), the active fragment of GHRH. In the original description, researchers attached a reactive maleimide group to a tetrasubstituted hGRF(1-29) so that the peptide bonds covalently to serum albumin after administration. The albumin-bound conjugates were more stable against the enzyme dipeptidyl peptidase-IV in vitro, and in rats CJC-1295 remained present in plasma beyond 72 hours, with an immunoreactive species detected on the albumin band.

Research-peptide listings label this albumin-binding form "CJC-1295 with DAC". The extended half-life findings below were measured for this albumin-binding form. Products sold as "CJC-1295 without DAC" lack that group, so the long-acting data should not be assumed to apply to them.

#### What is Ipamorelin?
Ipamorelin is a pentapeptide (Aib-His-D-2-Nal-D-Phe-Lys-NH2) developed at Novo Nordisk and described in 1998 as "the first selective growth hormone secretagogue". In rat pituitary cells it released GH with potency and efficacy similar to the older secretagogue GHRP-6, and antagonist profiling showed it acts through a GHRP-like receptor — the ghrelin receptor pathway.

Its distinguishing finding is selectivity. In swine, none of the secretagogues tested changed FSH, LH, prolactin or TSH; GHRP-6 and GHRP-2 raised ACTH and cortisol, but Ipamorelin did not raise ACTH or cortisol beyond the levels seen with GHRH stimulation, even at doses more than 200-fold above its ED50 for GH release.

#### CJC-1295 vs Ipamorelin at a glance
 | CJC-1295 (albumin-binding form) | Ipamorelin
Class | GHRH analog | Ghrelin-receptor agonist (GH secretagogue)
Receptor | GHRH receptor | GHS-R / ghrelin receptor
Structure | Tetrasubstituted hGRF(1-29) with an albumin-reactive maleimide group | Pentapeptide: Aib-His-D-2-Nal-D-Phe-Lys-NH2
Reported half-life (humans) | 5.8–8.1 days | About 2 hours
GH response pattern | Sustained elevation over days; pulsatility preserved | Single episode of GH release, peaking at about 0.67 h
Selectivity finding | Raised GH and IGF-I; no serious adverse reactions reported in the healthy-adult trials | No rise in ACTH or cortisol above GHRH levels in swine
Human research | Two placebo-controlled trials in healthy adults; GH pulsatility study | PK/PD study in healthy volunteers; Phase 2 post-operative ileus trial

#### How do the half-lives of CJC-1295 and Ipamorelin compare?
They differ by roughly two orders of magnitude. In two randomized, placebo-controlled, double-blind trials in healthy adults aged 21–61, the estimated half-life of CJC-1295 was 5.8–8.1 days. In a pharmacokinetic study in healthy male volunteers, Ipamorelin showed dose-proportional kinetics with a short terminal half-life of 2 hours.

GHRH itself is limited by a short duration of action, which was the stated motivation for developing a long-acting analog. CJC-1295's long half-life comes from albumin binding, not from the GHRH(1-29) sequence alone.

#### What has research found about CJC-1295?
- In healthy adults, a single administration produced dose-dependent increases in mean plasma GH of 2- to 10-fold lasting 6 days or more, and in mean IGF-I of 1.5- to 3-fold for 9–11 days. With repeated administration, mean IGF-I stayed above baseline for up to 28 days, and no serious adverse reactions were reported.
- A follow-up study sampled GH every 20 minutes overnight in healthy men. One week after CJC-1295, GH pulse frequency and magnitude were unchanged, but trough (basal) GH rose 7.5-fold, mean GH by 46% and IGF-I by 45%. The authors concluded that continuous GHRH stimulation increased GH secretion while preserving its pulsatile pattern.
- In rats, CJC-1295 produced a 4-fold larger GH area under the curve over 2 hours than unmodified hGRF(1-29).

The pulsatility result matters for how CJC-1295 is interpreted in research. GH is normally released in pulses, and pulsatile secretion is considered important for many of the hormone's physiological effects. A long-acting GHRH analog could, in principle, have flattened that pattern into a constant signal. Instead, the study found the pulse pattern intact while the baseline between pulses rose. Interestingly, the IGF-I increase did not correlate with any individual GH secretion parameter; the authors pointed to the large rise in trough GH as the likely driver of the IGF-I effect.

#### What has research found about Ipamorelin?
- Pharmacology: GH release in rat pituitary cells, anesthetized rats and conscious swine, with potency comparable to GHRP-6 and selectivity for GH over ACTH and cortisol.
- Human PK/PD: each exposure produced a single episode of GH release with a peak at about 0.67 hours, followed by exponential decline; variability between individuals was larger for the GH response than for the drug's kinetics.
- Clinical research: a multicenter Phase 2, randomized, placebo-controlled trial tested Ipamorelin for post-operative ileus after bowel resection (114 patients analyzed). It was well tolerated, but there were no significant differences from placebo in the key or secondary efficacy endpoints.

That last result is a useful reminder: activity at a receptor in pharmacology studies does not guarantee an effect on a clinical endpoint. Neither compound is an approved drug.

#### Why are CJC-1295 and Ipamorelin studied together?
Because they act through different receptors — the GHRH receptor and the ghrelin receptor, which represent distinct mechanisms for regulating GH release  — the two are frequently paired in GH-axis research designs. The published human data summarized above come from studies of each compound on its own; we are not aware of a peer-reviewed clinical study of the combination, so claims about how the pair performs together should be treated with caution.

ResearchChem carries the pairing as the CJC-1295 + Ipamorelin stack (5mg + 5mg), Ipamorelin on its own (10mg), and Tesamorelin, another GHRH analog that is often compared with this stack. Each is listed at 99.6% HPLC purity and stored at -20°C as a lyophilized powder; the certificate of analysis for any lot is available on request — see how to read a peptide COA.

All ResearchChem products are laboratory reagents for in-vitro research use only. They are not for human or veterinary use, and nothing in this article is medical advice or guidance on use.

#### FAQ
Q: What is the difference between CJC-1295 and Ipamorelin?
A: CJC-1295 is a GHRH analog that acts on the GHRH receptor and, in its albumin-binding form, has a half-life of about 6–8 days. Ipamorelin is a pentapeptide ghrelin-receptor agonist with a half-life of about 2 hours.

Q: What is the half-life of CJC-1295?
A: In healthy-adult trials of the albumin-binding (DAC) form, the estimated half-life was 5.8–8.1 days. That figure should not be assumed for CJC-1295 without DAC, which lacks the albumin-binding group.

Q: What is the half-life of Ipamorelin?
A: A pharmacokinetic study in healthy volunteers reported a terminal half-life of about 2 hours.

Q: Why is Ipamorelin called selective?
A: In the 1998 pharmacology study, Ipamorelin released GH without raising ACTH or cortisol above GHRH levels, unlike GHRP-6 and GHRP-2, and none of the secretagogues tested changed FSH, LH, prolactin or TSH.

Q: Does CJC-1295 stop natural GH pulses?
A: Not in the published study. Overnight sampling in healthy men one week after CJC-1295 showed unchanged GH pulse frequency and magnitude, with a 7.5-fold rise in trough GH between pulses.

Q: Are CJC-1295 or Ipamorelin approved drugs?
A: No. Both have been studied in clinical research, but neither is an approved medicine. ResearchChem sells them strictly as research-use-only laboratory reagents.

#### Sources
1. Howard AD, Feighner SD, Cully DF, et al. A receptor in pituitary and hypothalamus that functions in growth hormone release. Science. 273(5277):974–977 (1996). PMID 8688086
2. Kojima M, Hosoda H, Date Y, et al. Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature. 402(6762):656–660 (1999). PMID 10604470
3. Jetté L, Léger R, Thibaudeau K, et al. Human growth hormone-releasing factor (hGRF)1-29-albumin bioconjugates activate the GRF receptor on the anterior pituitary in rats: identification of CJC-1295 as a long-lasting GRF analog. Endocrinology. 146(7):3052–3058 (2005). PMID 15817669
4. Teichman SL, Neale A, Lawrence B, et al. Prolonged stimulation of growth hormone (GH) and insulin-like growth factor I secretion by CJC-1295, a long-acting analog of GH-releasing hormone, in healthy adults. J Clin Endocrinol Metab. 91(3):799–805 (2006). PMID 16352683
5. Ionescu M, Frohman LA. Pulsatile secretion of growth hormone (GH) persists during continuous stimulation by CJC-1295, a long-acting GH-releasing hormone analog. J Clin Endocrinol Metab. 91(12):4792–4797 (2006). PMID 17018654
6. Raun K, Hansen BS, Johansen NL, et al. Ipamorelin, the first selective growth hormone secretagogue. Eur J Endocrinol. 139(5):552–561 (1998). PMID 9849822
7. Gobburu JV, Agersø H, Jusko WJ, Ynddal L. Pharmacokinetic-pharmacodynamic modeling of ipamorelin, a growth hormone releasing peptide, in human volunteers. Pharm Res. 16(9):1412–1416 (1999). PMID 10496658
8. Beck DE, Sweeney WB, McCarter MD; Ipamorelin 201 Study Group. Prospective, randomized, controlled, proof-of-concept study of the ghrelin mimetic ipamorelin for the management of postoperative ileus in bowel resection patients. Int J Colorectal Dis. 29(12):1527–1534 (2014). PMID 25331030

## Key pages

- Shop: https://researchchem.org/shop
- Research standards & testing: https://researchchem.org/research
- FAQ: https://researchchem.org/faq
- Shipping: https://researchchem.org/shipping
- About: https://researchchem.org/about
- Contact: https://researchchem.org/contact
- Full catalog detail for AI assistants: https://researchchem.org/llms-full.txt